About
Antiparasitic therapies for infestations such as head lice and scabies
Areas of Focus
Categories
Small Molecule PharmaceuticalMidwest
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
1,923
By Phase
PHASE3: 4PHASE4: 1PHASE1: 3PHASE2: 3
By Status
COMPLETED: 11
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Today
Hover over trial bars to see details
Recent Trials
NCT02485704Lead Sponsor
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
PHASE3Completed
280 participants
Started: May 10, 2017 · Completed: Aug 3, 2018
NCT02485717Lead Sponsor
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
PHASE3Completed
291 participants
Started: May 2, 2017 · Completed: Jun 25, 2018
NCT01660321Lead Sponsor
Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
PHASE4Completed
26 participants
Started: Sep 30, 2011 · Completed: Mar 31, 2012
NCT00605956Lead Sponsor
NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers
PHASE1Completed
65 participants
Started: Jan 31, 2008 · Completed: Feb 29, 2008
NCT00591331Lead Sponsor
Phototoxicity Potential of NatrOVA Creme Rinse - 1%
PHASE1Completed
37 participants
Started: Dec 31, 2007 · Completed: Dec 31, 2007
Locations (1)
Headquarters
Carmel, IN, United States
Map
Loading map...